Literature DB >> 20554402

Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy.

Jennifer J Kurinczuk1, Melanie White-Koning, Nadia Badawi.   

Abstract

Neonatal encephalopathy (NE) is the clinical manifestation of disordered neonatal brain function. Lack of universal agreed definitions of NE and the sub-group with hypoxic-ischaemia (HIE) makes the estimation of incidence and the identification of risk factors problematic. NE incidence is estimated as 3.0 per 1000 live births (95%CI 2.7 to 3.3) and for HIE is 1.5 (95%CI 1.3 to 1.7). The risk factors for NE vary between developed and developing countries with growth restriction the strongest in the former and twin pregnancy in the latter. Potentially modifiable risk factors include maternal thyroid disease, receipt of antenatal care, infection and aspects of the management of labour and delivery, although indications for some interventions were not reported and may represent a response to fetal compromise rather than the cause. It is estimated that 30% of cases of NE in developed populations and 60% in developing populations have some evidence of intrapartum hypoxic-ischaemia. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20554402     DOI: 10.1016/j.earlhumdev.2010.05.010

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  287 in total

1.  Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study.

Authors:  H Aly; H Elmahdy; M El-Dib; M Rowisha; M Awny; T El-Gohary; M Elbatch; M Hamisa; A-R El-Mashad
Journal:  J Perinatol       Date:  2014-11-13       Impact factor: 2.521

Review 2.  A Critical Evaluation of Current Concepts in Cerebral Palsy.

Authors:  Joline E Brandenburg; Matthew J Fogarty; Gary C Sieck
Journal:  Physiology (Bethesda)       Date:  2019-05-01

3.  Extracting Interesting Rules from Gestation Course Data for Early Diagnosis of Neonatal Hypoxia.

Authors:  Inna Skarga-Bandurova; Tetiana Biloborodova; Maksym Nesterov
Journal:  J Med Syst       Date:  2018-12-01       Impact factor: 4.460

4.  Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain.

Authors:  Linus Olson; Stuart Faulkner; Karin Lundströmer; Aron Kerenyi; Dorka Kelen; M Chandrasekaran; Ulrika Ådén; Lars Olson; Xavier Golay; Hugo Lagercrantz; Nicola J Robertson; Dagmar Galter
Journal:  Transl Stroke Res       Date:  2012-10-14       Impact factor: 6.829

5.  Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins.

Authors:  Olayemi O Adeoye; Stacy M Butler; Margaret C Hubbell; Andrew Semotiuk; James M Williams; William J Pearce
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-16       Impact factor: 4.249

Review 6.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

Review 7.  Pharmacologic neuroprotective strategies in neonatal brain injury.

Authors:  Sandra E Juul; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

8.  Late failure of cerebral autoregulation in hypoxic-ischemic encephalopathy is associated with brain injury: a pilot study.

Authors:  Zachary A Vesoulis; Steve M Liao; Amit M Mathur
Journal:  Physiol Meas       Date:  2018-12-07       Impact factor: 2.833

9.  Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model.

Authors:  Pattaraporn T Chun; Ronald J McPherson; Luke C Marney; Sahar Z Zangeneh; Brendon A Parsons; Ali Shojaie; Robert E Synovec; Sandra E Juul
Journal:  Dev Neurosci       Date:  2015-02-27       Impact factor: 2.984

10.  ERP evidence of preserved early memory function in term infants with neonatal encephalopathy following therapeutic hypothermia.

Authors:  Katie M Pfister; Lei Zhang; Neely C Miller; Solveig Hultgren; Chris J Boys; Michael K Georgieff
Journal:  Pediatr Res       Date:  2016-08-16       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.